Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Hepatocellular

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 530 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Recruiting

Innovative Diagnosis and Therapy in LDLT Patients With High-risk Hepatocellular Carcinoma

NCT06327269

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Department of Surgery Kaohsiung City, Taiwan

View Trial Details

Recruiting

A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

NCT06363825

Conditions: Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +9 more
Locations: Xinhua Chen Fuzhou, China

View Trial Details

Recruiting

Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer

NCT06363006

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Chinese Academy of Medical Sciences & Peking Union Medical College Hospital (CAMS&PUMCH) Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Liver Embolization Approaches for Tumor Management

NCT05714124

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +32 more
Locations: IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Recruiting

Immunotherapy for Hepatocellular Carcinoma

NCT06241326

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC

NCT05652920

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

Hunan Cancer Hospital Changsha, Hunan, China

The first hospital of Jilin University Changchun, Jilin, China

West China Hospital Chengdu, Sichuan, China

View Trial Details

Recruiting

A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

NCT06326502

Conditions: Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +11 more
Locations: Seoul National University Hospital Seoul, South Korea

Severance Hospital Seoul, South Korea

View Trial Details

Recruiting

Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)

NCT06261125

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Mian Xi Guangzhou, Guangdong, China

View Trial Details

Recruiting

Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma

NCT05970666

Conditions: Adebrelimab, Adenocarcinoma, Bevacizumab, +13 more
Locations: The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

View Trial Details

Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

NCT04282044

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +64 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Stanford University Stanford, California, United States

View Trial Details